The London-based brokerage filed confidential IPO paperwork in February 2025, and the company appears to be targeting a $5 billion valuation, after being valued at $3.5 billion in early 2023.

In 2025, about ten mainboard initial public offerings (IPOs) have made their debuts; despite market volatility, six of the ...

US IPO activity saw a meaningful recovery in 2024, with 38% more IPOs and 48% higher proceeds. 2025 may bring even more ...

A sizable medical device company and a handful of small issuers went public in the first week of March, though a ...

The Washington-based firm is expecting to sell $4 billion to $5 billion in assets this year either through IPOs or the sale of existing investments, roughly in line with the $5 billion of exits ...